noom glp-1 companion Why We Launched GLP-1RX Noom: Lose weight and keep
Description
Comment on Kom et al
Participants taking the highest maintenance dose lost an average of 15 percent of their body weight by week 68, compared to 2.4 percent in the placebo group
Tirzepatide is taken in a once-weekly injection
BMJ 330, 13041305
To sign up, visit the custom Omada web page for your specific employer or plan
These symptoms usually improve as your body adjusts
